Molecular mechanisms of BMP-induced bone formation: Cross-talk between BMP and NF-κB signaling pathways in osteoblastogenesis

Aubin, 2002, Mesenchymal stem cells and osteoblast differentiation, 59 Mundy, 1996, Regulation of bone formation by bone morphogenetic proteins and other growth factors, Clin Orthop Relat Res, 324, 24, 10.1097/00003086-199603000-00004 Nishimura, 2008, Signal transduction and transcriptional regulation during mesenchymal cell differentiation, J Bone Miner Metab, 26, 203, 10.1007/s00774-007-0824-2 Katagiri, 2002, Regulatory mechanisms of osteoblast and osteoclast differentiation, Oral Dis, 8, 147, 10.1034/j.1601-0825.2002.01829.x Urist, 1965, Bone: formation by autoinduction, Science, 150, 893, 10.1126/science.150.3698.893 Wozney, 1988, Novel regulators of bone formation: molecular clones and activities, Science, 242, 1528, 10.1126/science.3201241 Kusumoto, 2002, Osteoinduction by recombinant human bone morphogenetic protein-2 in muscles of non-human primates, J Int Med Res, 30, 251, 10.1177/147323000203000305 Vaidya, 2008, Complications in the use of rhBMP-2 in PEEK cages for interbody spinal fusions, J Spinal Disord Tech, 21, 557, 10.1097/BSD.0b013e31815ea897 Buma, 2008, No effect of bone morphogenetic protein-7 (OP-1) on the incorporation of impacted bone grafts in a realistic acetabular model, J Biomed Mater Res B: Appl Biomater, 84, 231, 10.1002/jbm.b.30865 Canalis, 1987, Effects of tumor necrosis factor on bone formation in vitro, Endocrinology, 121, 1596, 10.1210/endo-121-5-1596 Nakase, 1997, Interleukin-1β enhances and tumor necrosis factor-α inhibits bone morphogenetic protein-2-induced alkaline phosphatase activity in MC3T3-E1 osteoblastic cells, Bone, 21, 17, 10.1016/S8756-3282(97)00038-0 Nanes, 2003, Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology, Gene, 321, 1, 10.1016/S0378-1119(03)00841-2 Li, 2008, Positive and negative signaling components involved in TNFα-induced NF-κB activation, Cytokine, 41, 1, 10.1016/j.cyto.2007.09.016 Bradley, 2008, TNF-mediated inflammatory disease, J Parhol, 214, 149, 10.1002/path.2287 Ghosh, 2008, New regulators of NF-κB in inflammation, Nat Rev Immunol, 8, 837, 10.1038/nri2423 Karin, 2008, The IκB kinase—a bridge between inflammation and cancer, Cell Res, 18, 334, 10.1038/cr.2008.30 ten Dijke, 2006, Bone morphogenetic protein signal transduction in bone, Curr Med Res Opin, 22, S7, 10.1185/030079906X80576 Haÿ, 2001, Bone morphogenetic protein-2 promotes osteoblast apoptosis through a Smad-independent, protein kinase C-dependent signaling pathway, J Biol Chem, 276, 29028, 10.1074/jbc.M011265200 Haÿ, 2004, Bone morphogenetic protein receptor IB signaling mediates apoptosis independently of differentiation in osteoblastic cells, J Biol Chem, 279, 1650, 10.1074/jbc.M300969200 Young, 1992, Structure, expression, and regulation of the major noncollagenous matrix proteins of bone, Clin Orthop, 281, 275, 10.1097/00003086-199208000-00042 Robey, 1993, Structure and molecular regulation of bone matrix proteins, J Bone Miner Res Suppl, 2, S483 Mundlos, 1997, Heritable diseases of the skeleton. Part II. Molecular insights into skeletal development-matrix components and their homeostasis, FASEB J, 11, 227, 10.1096/fasebj.11.4.9068611 Komori, 2006, Regulation of osteoblast differentiation by transcription factors, J Cell Biochem, 99, 1233, 10.1002/jcb.20958 Wan, 2005, BMP signaling in skeletal development, Biochem Biophys Res Commun, 328, 651, 10.1016/j.bbrc.2004.11.067 Katagiri, 2007, The bone morphogenetic proteins, 121 Ebisawa, 1999, Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation, J Cell Sci, 112, 3519, 10.1242/jcs.112.20.3519 Aoki, 2001, Synergistic effects of different bone morphogenetic protein type I receptors on alkaline phosphatase induction, J Cell Sci, 114, 1483, 10.1242/jcs.114.8.1483 Yamaguchi, 2000, Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1, Endocr Rev, 21, 393, 10.1210/edrv.21.4.0403 Taylor, 1979, Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine, Cell, 17, 771, 10.1016/0092-8674(79)90317-9 Katagiri, 1990, The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2, Biochem Biophys Res Commun, 172, 295, 10.1016/S0006-291X(05)80208-6 Ahrens, 1993, Expression of human bone morphogenetic proteins-2 or -4 in murine mesenchymal progenitor C3H10T1/2 cells induces differentiation into distinct mesenchymal cell lineages, DNA Cell Biol, 12, 871, 10.1089/dna.1993.12.871 Wang, 1993, Bone morphogenetic protein-2 causes commitment and differentiation in C3H10T1/2 and 3T3 cells, Growth Factors, 9, 57, 10.3109/08977199308991582 Yamaguchi, 1991, Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro, J Cell Biol, 113, 681, 10.1083/jcb.113.3.681 Katagiri, 1994, Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage, J Cell Biol, 127, 1755, 10.1083/jcb.127.6.1755 Yamamoto, 1997, Smad1 and smad5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts, Biochem Biophys Res Commun, 238, 574, 10.1006/bbrc.1997.7325 Kingsley, 1992, The mouse short ear skeletal morphogenesis locus is associated with defects in a bone morphogenetic member of the TGF β superfamily, Cell, 71, 399, 10.1016/0092-8674(92)90510-J Solloway, 1998, Mice lacking Bmp6 function, Dev Genet, 22, 321, 10.1002/(SICI)1520-6408(1998)22:4<321::AID-DVG3>3.0.CO;2-8 Dudley, 1995, A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye, Genes Dev, 9, 2795, 10.1101/gad.9.22.2795 Luo, 1995, BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning, Genes Dev, 9, 2808, 10.1101/gad.9.22.2808 Katagiri, 1998, Skeletal abnormalities in doubly heterozygous Bmp4 and Bmp7 mice, Dev Genet, 22, 340, 10.1002/(SICI)1520-6408(1998)22:4<340::AID-DVG4>3.0.CO;2-6 Settle, 2003, Multiple joint and skeletal patterning defects caused by single and double mutations in the mouse Gdf6 and Gdf5 genes, Dev Biol, 254, 116, 10.1016/S0012-1606(02)00022-2 McPherron, 1999, Regulation of anterior/posterior patterning of the axial skeleton by growth/differentiation factor 11, Nat Genet, 22, 260, 10.1038/10320 Zhao, 2002, Bone morphogenetic protein receptor signaling is necessary for normal murine postnatal bone formation, J Cell Biol, 157, 1049, 10.1083/jcb.200109012 Daluiski, 2001, Bone morphogenetic protein-3 is a negative regulator of bone density, Nat Genet, 27, 84, 10.1038/83810 Thomas, 1996, A human chondrodysplasia due to a mutation in a TGF-β superfamily member, Nat Genet, 12, 315, 10.1038/ng0396-315 Gong, 1999, Heterozygous mutations in the gene encoding noggin affect human joint morphogenesis, Nat Genet, 21, 302, 10.1038/6821 Shore, 2006, A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva, Nat Genet, 38, 525, 10.1038/ng1783 Fukuda, 2009, Constitutively activated ALK2 and increased SMAD1/5 cooperatively induce bone morphogenetic protein signaling in fibrodysplasia ossificans progressiva, J Biol Chem, 284, 7149, 10.1074/jbc.M801681200 Fukuda, 2008, A unique mutation of ALK2, G356D, found in a patient with fibrodysplasia ossificans progressiva is a moderately activated BMP type I receptor, Biochem Biophys Res Commun, 377, 905, 10.1016/j.bbrc.2008.10.093 Hanai, 1999, Interaction and functional cooperation of PEBP2/CBF with Smads. Synergistic induction of the immunoglobulin germline Calpha promoter, J Biol Chem, 274, 31577, 10.1074/jbc.274.44.31577 Zhang, 2000, A RUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia, Proc Natl Acad Sci USA, 97, 10549, 10.1073/pnas.180309597 Lee, 2000, Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12, Mol Cell Biol, 20, 8783, 10.1128/MCB.20.23.8783-8792.2000 Nishimura, 2002, Core binding factor alpha 1 (Cbfa1) induces osteoblastic differentiation of C2C12 cells without interactions with Smad1 and Smad5, Bone, 31, 303, 10.1016/S8756-3282(02)00826-8 Yoshida, 2000, Negative regulation of BMP/Smad signaling by Tob in osteoblasts, Cell, 103, 1085, 10.1016/S0092-8674(00)00211-7 Alliston, 2001, TGFβ-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation, EMBO J, 20, 2254, 10.1093/emboj/20.9.2254 Harada, 1999, Cbfa1 isoforms exert functional differences in osteoblast differentiation, J Biol Chem, 274, 6972, 10.1074/jbc.274.11.6972 Liu, 2001, Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures, J Cell Biol, 155, 157, 10.1083/jcb.200105052 Geoffroy, 2002, High bone resorption in adult aging transgenic mice overexpressing cbfa1/runx2 in cells of the osteoblastic lineage, Mol Cell Biol, 22, 6222, 10.1128/MCB.22.17.6222-6233.2002 Gutierrez, 2002, CCAAT/enhancer-binding proteins (C/EBP) beta and delta activate osteocalcin gene transcription and synergize with Runx2 at the C/EBP element to regulate bone-specific expression, J Biol Chem, 277, 1316, 10.1074/jbc.M106611200 Hata, 2005, A CCAAT/enhancer binding protein beta isoform, liver-enriched inhibitory protein, regulates commitment of osteoblasts and adipocytes, Mol Cell Biol, 25, 1971, 10.1128/MCB.25.5.1971-1979.2005 Nakashima, 2002, The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation, Cell, 108, 17, 10.1016/S0092-8674(01)00622-5 Koga, 2005, NFAT and osterix cooperatively regulate bone formation, Nat Med, 11, 880, 10.1038/nm1270 Pacifici, 1991, Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells, Proc Natl Acad Sci USA, 88, 5134, 10.1073/pnas.88.12.5134 Ammann, 1997, Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency, J Clin Invest, 99, 1699, 10.1172/JCI119333 Choy, 2001, Cytokine pathways and joint inflammation in rheumatoid arthritis, N Engl J Med, 344, 907, 10.1056/NEJM200103223441207 Ranganathan, 2008, An update on pharmacogenomics in rheumatoid arthritis with a focus on TNF-blocking agents, Curr Opin Mol Ther, 10, 562 Kaneki, 2006, Tumor necrosis factor promotes Runx2 degradation through up-regulation of Smurf1 and Smurf2 in osteoblasts, J Biol Chem, 281, 4326, 10.1074/jbc.M509430200 Mukai, 2007, TNF-α inhibits BMP-induced osteoblast differentiation through activating SAPK/JNK signaling, Biochem Biophys Res Commun, 356, 1004, 10.1016/j.bbrc.2007.03.099 May, 2000, Selective inhibition of NF-κB activation by a peptide that blocks the interaction of NEMO with the IκB kinase complex, Science, 289, 1550, 10.1126/science.289.5484.1550 Guttridge, 2000, NF-κB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia, Science, 289, 2363, 10.1126/science.289.5488.2363 Arkan, 2005, IKKβ links inflammation to obesity-induced insulin resistance, Nat Med, 11, 191, 10.1038/nm1185 Jimi, 2004, Selective inhibition of NF-κB blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo, Nat Med, 10, 617, 10.1038/nm1054 Ruocco, 2005, IκB kinase β, but not IKKα, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss, J Exp Med, 201, 1677, 10.1084/jem.20042081 Eliseev, 2006, Smad7 mediates inhibition of Saos2 osteosarcoma cell differentiation by NF-κB, Exp Cell Res, 312, 40, 10.1016/j.yexcr.2005.09.016 Li, 2007, Endogenous TNFα lowers maximum peak bone mass and inhibits osteoblastic Smad activation through NF-κB, J Bone Miner Res, 22, 646, 10.1359/jbmr.070121 Yamazaki M, Fukushima H, Shin M, Katagiri T, Doi T, Takahashi T, et al. TNFα represses BMP signaling by interfering with DNA binding of Smads through the activation of NF-κB. J Biol Chem, in press. Chang, 2009, Inhibition of osteoblastic bone formation by nuclear factor-κB, Nat Med, 15, 682, 10.1038/nm.1954